Dong'e Ejiao Co., Ltd., founded in 1952, is a national standard setter of Chinese herbal medicines, and a large-scale manufacturer of Ejiao series products mainly engaged in Chinese patent medicines/health products/biological drugs
History:Dong'e Ejiao Co., Ltd. is a state-owned enterpriseChina Resources Group, formerly known as Shandong Dong'e Ejiao Factory, was established in 1952 and reorganized from a state-owned enterprise to a joint-stock enterprise in 1993. In 1996, it became a listed company, and on July 29 of the same year, the A-share stock of "Dong'e Ejiao" was listed on the Shenzhen Stock Exchange.
It is a national high-tech enterprise, a national innovative enterprise, a national engineering technology research center for colloidal traditional Chinese medicine, a national standard setter for glue traditional Chinese medicine, a national comprehensive new drug research and development technology platform industrialization demonstration enterprise, and a representative inheritor enterprise of the national intangible cultural heritage Dong'e Ejiao production technology.
Operational Performance:"Dong'e" brand Ejiao is the only Ejiao manufacturer in the country to win the national gold medal for 3 times, and the only to win the international gold medal of traditional medicine "Great Wall"; Shanghai World Expo "Millennium Gold Award" and "National Customer Satisfaction Product" title; The only one to be shortlisted for 8 times in the "China's 500 Most Valuable Brands"; Won the first batch of 300 "National Key Protection Brands"; "China's Top 500 Famous Science and Technology Brands"; Influencing the world's top 500 Chinese power brands; Iconic brand in China's industry; "The most trusted health care product brand by consumers"; "The most assured enterprise and the most assured brand"; Among the top ten blood tonic brands in China, 7 indicators, including the first mention rate, the most common taking rate, the attempt rate, and brand loyalty, topped the list. The brand value is 10.605 billion.
The only Ejiao manufacturer in the country won the 2013 National Quality Award Nomination Award, and the only enterprise and operator in the province won the Governor's Quality Award, which is a time-honored brand in China; The two trademarks "Dong'e" and "Jixiangyun" are well-known protection; It took the lead in passing the three certifications of GMP, ISO9001 quality system and ISO14001 international environmental system in the same industry in the country, and entered the top 100 pharmaceutical enterprises in China, the top 100 in science and technology in China, and the top ten enterprises in the national traditional Chinese medicine industry. China's top 100 most viable enterprises; It has been shortlisted as one of the "Top 50 Most Promising Listed Companies in China" for 7 consecutive times; Ranked first in the tonic category of China's pharmaceutical brand list for six consecutive years; It has been shortlisted as one of the top 20 most competitive pharmaceutical listed companies in China for four consecutive years; "Best Internal Corporate Governance"; "Top 10 Most Valuable Pharmaceutical Listed Companies"; "2013 Top 100 Enterprises of Internal Control of Listed Companies in China"; Won the national pioneer in the traditional Chinese medicine industry; Top 50 National Informatization Integration; Best Employer Companies; National Science Education Base; Star of China's pharmaceutical quality management.
Ejiao Biotechnology Park is a key project of Dong'e Ejiao Co., Ltd. in the "Twelfth Five-Year Plan", covering an area of 512 acres, with an annual output value of 10 billion yuan and profits and taxes of 3 billion yuan after completion.
The project is planned by 5 design company in the United States, integrating production, logistics, industrial tourism, experience and other service functions. The project achieves three highs and three lows: "three highs" are: high standards (cGMP standards in China, the United States and Europe, product quality standards have been leading the industry for 20 years), high quality (online testing), and high returns (40% profit and tax rate of output value); "Three lows": low energy consumption (photovoltaic power generation of 5 megawatts, to meet 50% of the park's electricity, low-temperature extraction and concentration technology, comprehensive energy consumption of 68 kg of standard coal per 10,000 yuan output value, all of which are leading in the national industry), low emission (90% recycling of sewage, utilization of pharmaceutical residue), low pollution. The production workshop is designed with reference to the new national GMP, the US FDA and the EU GMP standards, and the tourism is designed according to the environmental standards of 5A-level industrial tourist attractions.
The project is the only Ejiao manufacturer in China and the leading level in the industry. After the completion of the project, together with Dong'e Ejiao City, it will become a large health industry base for Dong'e Ejiao to enter the whole industrial chain of tourism, health experience, and manufacturing and sales of traditional Chinese medicine and biological drugs.
